[go: up one dir, main page]

ATE442366T1 - Oxazolidinonderivate und ihre verwendung als antibiotika - Google Patents

Oxazolidinonderivate und ihre verwendung als antibiotika

Info

Publication number
ATE442366T1
ATE442366T1 AT06763881T AT06763881T ATE442366T1 AT E442366 T1 ATE442366 T1 AT E442366T1 AT 06763881 T AT06763881 T AT 06763881T AT 06763881 T AT06763881 T AT 06763881T AT E442366 T1 ATE442366 T1 AT E442366T1
Authority
AT
Austria
Prior art keywords
antibiotics
oxazolidinone derivatives
oxazolidinone
derivatives
Prior art date
Application number
AT06763881T
Other languages
English (en)
Inventor
Montserrat Cano
Albert Palomer
Antonio Guglietta
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34982564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE442366(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Application granted granted Critical
Publication of ATE442366T1 publication Critical patent/ATE442366T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT06763881T 2005-06-27 2006-06-26 Oxazolidinonderivate und ihre verwendung als antibiotika ATE442366T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05105714A EP1745784A1 (de) 2005-06-27 2005-06-27 Oxazolidinonderivate und ihre Anwendung als Antibiotika
PCT/EP2006/063541 WO2007000432A1 (en) 2005-06-27 2006-06-26 Oxazolidinone derivatives and use thereof as antibiotics

Publications (1)

Publication Number Publication Date
ATE442366T1 true ATE442366T1 (de) 2009-09-15

Family

ID=34982564

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06763881T ATE442366T1 (de) 2005-06-27 2006-06-26 Oxazolidinonderivate und ihre verwendung als antibiotika

Country Status (23)

Country Link
US (1) US7759351B2 (de)
EP (2) EP1745784A1 (de)
JP (1) JP2008543963A (de)
KR (1) KR20080020696A (de)
CN (1) CN101248067A (de)
AR (1) AR054625A1 (de)
AT (1) ATE442366T1 (de)
AU (1) AU2006263880A1 (de)
BR (1) BRPI0612559A2 (de)
CA (1) CA2612969A1 (de)
CY (1) CY1109544T1 (de)
DE (1) DE602006009112D1 (de)
DK (1) DK1902050T3 (de)
ES (1) ES2333469T3 (de)
HK (1) HK1116482A1 (de)
MX (1) MX2007016329A (de)
NO (1) NO20080536L (de)
PL (1) PL1902050T3 (de)
PT (1) PT1902050E (de)
RU (1) RU2417223C2 (de)
SI (1) SI1902050T1 (de)
TW (1) TWI324603B (de)
WO (1) WO2007000432A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2225226B1 (de) 2007-12-26 2016-08-17 Critical Outcome Technologies, Inc. Verbindungen und ihre verwending in einem verfahren zur behandlung von krebs
WO2010006438A1 (en) 2008-07-17 2010-01-21 Critical Outcome Technologies Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
CN102224151A (zh) 2008-11-20 2011-10-19 万能药生物有限公司 新的抗微生物剂
CN102803224A (zh) 2009-06-26 2012-11-28 万能药生物有限公司 新的氮杂双环己烷类化合物
CA2999435A1 (en) 2010-04-01 2011-10-06 Critical Outcome Technologies Inc. Compounds and method for treatment of hiv
US20160152579A1 (en) * 2013-07-11 2016-06-02 Servicio Andaluz De Salud Oxazolidinone derivatives as ppar ligands
CN103420995B (zh) * 2013-09-07 2015-07-01 吉首大学 噁唑烷酮-烷胺基-呋喃酮型化合物及其制法和用途
CN104447730B (zh) * 2014-12-05 2017-11-07 广东东阳光药业有限公司 噁唑烷酮类化合物及其在药物中的应用
TWI614256B (zh) 2017-05-26 2018-02-11 合成四氫異喹啉噁唑烷的方法
CN111164071A (zh) * 2017-09-28 2020-05-15 株式会社Lg化学 用于合成药物的中间体化合物的制备方法
MX2022016063A (es) 2020-06-18 2023-04-11 Akagera Medicines Inc Compuestos de oxazolidinona, composiciones de liposomas que comprenden compuestos de oxazolidinona y metodos de uso de los mismos.
CN115466253B (zh) * 2021-06-16 2024-08-20 沈阳药科大学 含二硫代氨基甲酸酯结构的噁唑烷酮类化合物及其制备方法
CN113880821B (zh) * 2021-10-29 2024-03-12 南京碳硅人工智能生物医药技术研究院有限公司 一类双光子荧光探针对癫痫脑内次氯酸特征成像的荧光探针设计及其合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003048136A1 (en) * 2001-11-29 2003-06-12 Merck & Co., Inc. Cyclopropyl hexane containing oxazolidinone antibiotics and derivatives thereof
CA2492194A1 (en) * 2002-07-11 2004-01-22 Wockhardt Limited Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoproteins sites
WO2004089944A1 (en) * 2003-04-07 2004-10-21 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials

Also Published As

Publication number Publication date
EP1902050B1 (de) 2009-09-09
JP2008543963A (ja) 2008-12-04
DK1902050T3 (da) 2010-01-04
MX2007016329A (es) 2008-03-10
AU2006263880A1 (en) 2007-01-04
KR20080020696A (ko) 2008-03-05
EP1745784A1 (de) 2007-01-24
SI1902050T1 (sl) 2010-01-29
CA2612969A1 (en) 2007-01-04
ES2333469T3 (es) 2010-02-22
AR054625A1 (es) 2007-07-04
EP1902050A1 (de) 2008-03-26
RU2008102597A (ru) 2009-08-10
US7759351B2 (en) 2010-07-20
NO20080536L (no) 2008-03-14
PL1902050T3 (pl) 2010-03-31
TW200740800A (en) 2007-11-01
US20090062266A1 (en) 2009-03-05
TWI324603B (en) 2010-05-11
PT1902050E (pt) 2009-11-27
DE602006009112D1 (de) 2009-10-22
RU2417223C2 (ru) 2011-04-27
CN101248067A (zh) 2008-08-20
HK1116482A1 (en) 2008-12-24
BRPI0612559A2 (pt) 2010-11-23
WO2007000432A1 (en) 2007-01-04
CY1109544T1 (el) 2014-08-13

Similar Documents

Publication Publication Date Title
ATE442366T1 (de) Oxazolidinonderivate und ihre verwendung als antibiotika
EP1955844A4 (de) Verbundfolie und verwendung davon
ATE450517T1 (de) Isoxazolinderivate und ihre verwendung als herbizide
ATE459605T1 (de) Isoxazolinderivate und deren verwendung als herbizide
ATE525374T1 (de) Heteroarylsubstituierte pyrroloä2,3-büpyridine und pyrroloä2,3-büpyrimidine als januskinaseinhibitoren
ATE543808T1 (de) 5,6-ring-annelierte indolderivate und ihre verwendung
EP1954140A4 (de) Glycerinlevulinatketale und ihre verwendung
DE602006015607D1 (de) Thiazol-4-carboxamid-derivate als mglur5-antagonisten
ATE470667T1 (de) Neue benzothiazinonderivate und ihre verwendung als antibakterielle mittel
EP1746902A4 (de) Multilektin-affiniätschromatografie und verwendung dafür
EP1896395A4 (de) Modifizierte malonatderivate
ATE478059T1 (de) Cinnamoylpiperazinderivate und ihre verwendung als par-1-antagonisten
EP1974370A4 (de) Mikroätzungszusammensetzung und verwendungsverfahren dafür
DE502005007106D1 (de) Substituierte phenylaminothiazole und ihre verwendung
DE602006004713D1 (de) Trifluormethylbenzamidderivate und therapeutische verwendungen dafür
ATE472549T1 (de) Octahydropyrroloä3,4-cüpyrrolderivate und ihre verwendung als antivirale mittel
ATE544752T1 (de) Aryloxyacetamidderivate und ihre verwendung als fungizide
DE602006009296D1 (de) Oligopeptide und ihre verwendung
ATE468338T1 (de) Pyrrolochinolinderivate und ihre verwendung als proteinkinasehemmer
ATE513817T1 (de) Pyrimidinderivate und ihre verwendung als pestizide
ATE511507T1 (de) Piperidinylcarbonylpyrrolidine und deren verwendung als melanocortinagonisten
DE602006008025D1 (de) Amidverbindungen und deren verwendung
DE602006003075D1 (de) Uracilen und 3-sulfonylisoxazolinen
ATE555097T1 (de) 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente
DE602006016104D1 (de) Neuartige oxadiazol-derivate und deren medizinische verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1902050

Country of ref document: EP